Scorpion Venom Could Be Used To Treat Breast Cancer
In a groundbreaking scientific development, Brazilian scientists have claimed that scorpion venom could help treat breast cancer. As per the study findings presented at FAPESP Week France, researchers at the University of Sao Paulo found a molecule in the scorpion venom that acts similarly to a commonly used chemotherapy drug, employed to kill the cancer cells.
Preliminary results of the study showed that the molecule called BamazScplp1, found in the venom of the Brotheas amazonicus scorpion, showed cancer-fighting properties when tested in the lab.
"Through bioprospecting, we were able to identify a molecule in the species of this Amazonian scorpion that is similar to that found in the venoms of other scorpions and that acts against breast cancer cells," said Eliane Candiani Arantes, a professor at the university and the project's coordinator.
Instead of milking the scorpions for venom, the researchers used a process called heterologous expression to produce the required toxin content for the study. In this process, the gene that produces a particular protein is inserted into another organism (often yeast or bacteria) and later produced in large quantities inside the lab.
"We also intend to obtain these molecules through heterologous expression," said Ms Arantes, referring to BamazScplp1 and other promising compounds.
"Our idea now is to obtain this serine protease through heterologous expression [in a fragment or complete gene from a host organism that doesn't have it naturally] in Pichia pastoris," she added.
Test results of the peptide on breast cancer cells revealed a response comparable to that of paclitaxel, a chemotherapy drug commonly used to treat the disease.
"The peptide induces cell death mainly through necrosis, an action similar to that of molecules identified in other scorpion species," the study highlighted.
Breast cancer
According to the World Health Organisation (WHO), breast cancer is the most common cancer type in women and the second most common cancer type overall, globally. A study published in Nature Medicine earlier this year revealed that on average, 1 in 20 women worldwide will be diagnosed with breast cancer in their lifetime.
If current rates continue, by 2050, there will be 3.2 million new breast cancer cases and 1.1 million breast cancer-related deaths per year.
An estimated 2.3 million new breast cancer cases and 670,000 breast cancer-related deaths occurred worldwide in 2022. Most breast cancer cases and deaths occur in individuals aged 50 years and older, who account for 71 per cent of new cases and 79 per cent of deaths.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
an hour ago
- Hindustan Times
Doctor says ‘immunity begins at home'; shares smarter habits for children against new COVID-19 variant
A new COVID-19 variant is on the rise, and has been identified as the "Nimbus" variant, also known as NB.1.8.1, known for causing a 'razor blade throat', per reports. The WHO assessed the additional risk to the global public as currently low, and existing COVID-19 vaccines to be effective in preventing severe disease. However, taking precautions, especially with kids, shouldn't be ignored. The new COVID variant appears to cause milder illness than earlier variants, but its rapid spread still poses a threat, particularly to children. Also Read | Salman Khan reveals struggle with brain aneurysm: Know about the medical condition, risk factors, diagnosis, treatment In an interview with HT Lifestyle, Dr Michelle Shah, paediatric lifestyle medicine specialist and public health professional, shared smarter habits to boost your child's immunity during the resurgence of the Omicron sub-variants like JN.1.16, LF.7, and NB.1.8.1 'India is once again seeing a gradual resurgence of COVID-19 cases, driven by highly transmissible Omicron sub-variants like JN.1.16, LF.7, and NB.1.8.1. Though these strains appear to cause milder illness than earlier variants, their rapid spread still poses a threat, particularly to children under 12 and those with chronic conditions such as asthma, diabetes, or immune compromise. Vaccination remains vital, but daily routines are what quietly train a child's immune system over time,' Dr Michelle said. These strains appear to cause milder illness than earlier variants, but their rapid spread still poses a threat. (Shutterstock) She suggested that families go beyond the basics to build immunity in ways that are science-backed, yet surprisingly simple. Here's what she suggested: 1. Feed the clock, not just the child 'Our immune cells follow circadian rhythms. Eating meals at consistent times (especially a protein-rich breakfast within 90 minutes of waking) can optimise immune regulation and reduce inflammatory markers. Erratic eating disrupts metabolic-immune synchrony,' Dr Michelle explained. 2. Introduce morning natural light before screens Morning sunlight within the first hour of waking helps reset the circadian clock and boosts serotonin production. 'It indirectly supports immune homeostasis. Open curtains, step outside or have breakfast near a window before reaching for devices,' she suggested. 3. Cultivate a weekly 'nature dose' 'Just 2 hours per week in green spaces reduces pro-inflammatory cytokines and enhances Natural Killer (NK) cell activity, your child's first line of viral defence. Whether it's a nature walk, outdoor story time or barefoot garden play, nature is medicine,' Dr Michelle said. 4. Teach the 'sun-sleep-soil' triangle Lastly, the expert advised empowering older children by teaching them a simple formula: 'Sunlight daily + Good sleep + Time in soil = Strong body soldiers.' 'Framing immunity as something they can 'train' makes them more likely to adopt healthy habits,' she added. Are our schools prepared? Dr Michelle also stressed that with rising cases, we must ask ourselves, 'Are our schools prepared?' Here's what schools and parents can do together: Ensure proper ventilation in classrooms and common areas. Cross-ventilation, open-air classrooms or simple HEPA filters can reduce airborne transmission effectively. Reinforce hand hygiene habits with handwashing stations. When handwashing is integrated into transitions (after play, before snacks), it stops being a 'rule' and becomes a reflex. Keep sick children at home. Staying home when unwell should be reframed as a civic contribution, not an inconvenience. Monitor absentee spikes to detect early signs of outbreaks. 'Let's not wait for the numbers to rise dramatically before reactivating basic safety protocols. A proactive approach can prevent the need for drastic measures later,' she concluded. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Indian Express
2 hours ago
- Indian Express
WHO lauds India's tobacco control tool of warning labels on cigarette packs: What we did right
Health warnings are an effective way to help people quit tobacco use and WHO has identified India among the countries having the best practices in graphic health warning labels in 2024. The WHO's Global Tobacco Epidemic 2025 report reveals that the most striking gains have been in graphic health warnings, one of the key measures under the WHO Framework Convention on Tobacco Control (FCTC), that make the harms of tobacco impossible to ignore. Currently, 110 countries with a total of five billion people are protected by strong graphic health warnings. This is an increase of 101 countries and 4.7 billion people since 2007. The average size of warnings has increased from 28% in 2007 to almost 60% in 2024. Dr Vinayak Mohan Prasad, head of the Global Tobacco Control Programme, WHO HQ, Geneva told The Indian Express that India had achieved the highest status in O and W categories, O meaning offering help to quit tobacco use and W meaning warning labels. It is in the second highest category for other measures including M, which means monitoring and mass media. 'Health warnings on cigarette packs are among the largest in the world at 85 per cent. Only 10 countries have a larger graphic health warning,' he said. While WHO officials said that adult daily smoking prevalence in India in 2023 was seven per cent, they have not made estimates for smokeless tobacco use. According to Dr Prasad, the prevalence of current tobacco use among adults in the country is trending down and is on track to meet the 2025 NCD GAP target (Global Action Plan for the Prevention and Control of Non-Communicable Diseases or NCDs, which includes tobacco control as a way of reducing premature mortality by one-third by 2030). 'However prevalence is still higher than the global average. The largest population (National Family Health Survey 2021) shows 38 per cent of men and 9 per cent of women are current users of tobacco while the global average in 2021 was 35 per cent among men and 8 per cent among women,' Dr Prasad said. He explained that smoking rates were lower than smokeless tobacco use among adults (Global Adult Tobacco Survey-2017 showed 11 per cent smoking and 21 per cent using smokeless tobacco). Among children aged 13-15 (Global Youth Tobacco Survey-2019) 8 per cent are using tobacco (7 per cent smoking and 4 per cent us smokeless tobacco) with little difference between boys and girls. Other than warning labels, India has banned smoking at all indoor public places, but still allows designated smoking rooms at restaurants/drinking facilities/nightclubs with a seating capacity of 30 or more as well as at airports and hotels. The government has banned direct and indirect tobacco advertising, promotion and sponsorships across all forms of media, including television, radio, print and digital platforms. 'However there is no ban on internet sales and India should completely ban advertising of tobacco products at points of sale,' said Dr Prasad. The WHO report said that India is reinforcing its commitment to public health and positioning itself as a pioneer in adapting regulation to evolving media consumption trends. However, it highlighted how the tobacco tax is the least-adopted measure though it's the most effective and efficient way to reduce tobacco use. In India cigarettes are still affordable as per the report. In 2024 only 15% of the world's population living in 40 countries were protected by tax at 75% or more of the price of the most popular brand of cigarette. (The author is in Dublin on the invitation of Vital Strategies) Anuradha Mascarenhas is a journalist with The Indian Express and is based in Pune. A senior editor, Anuradha writes on health, research developments in the field of science and environment and takes keen interest in covering women's issues. With a career spanning over 25 years, Anuradha has also led teams and often coordinated the edition. ... Read More
Hindustan Times
6 hours ago
- Hindustan Times
Harnessing India's medical colleges in the fight against TB
India has made undeniable progress in its battle against tuberculosis (TB). The World Health Organization (WHO) acknowledged a 17.7% drop in TB incidence in the country from 237 to 195 per lakh population between 2015 and 2023 – double the pace observed globally. Despite these advancements, India continues to bear the highest TB burden globally1, making the goal of a TB-free India even more urgent. Against this backdrop, medical colleges have emerged as vital players in the national TB response - providing a template for other disease programmes to tap into their potential for a healthier India. TB (AFP) Harnessing India's vast network of medical colleges is a cornerstone of the nation's ambitious strategy to eliminate TB by 2025. These institutions have transitioned from peripheral actors to central pillars in the fight against TB, contributing significantly to nearly every facet of the National Tuberculosis Elimination Programme (NTEP). Medical colleges have evolved beyond tertiary referral centres to become critical nodes in India's public health infrastructure and the TB elimination response. They serve patients from both within and beyond their districts and states, offering significant potential for case detection not just in TB and respiratory departments, but across all specialties. Equipped with advanced laboratories and specialised centres, nearly all of India's 651 medical colleges are working closely with the NTEP. Notably, 336 medical colleges have centres dedicated to managing drug-resistant TB, a more complex and harder-to-treat form of the disease. With cutting-edge diagnostic tools and clinical expertise in handling health complications, these institutions are leading to better TB care and outcomes. In 2023, medical colleges notified nearly 14% of all TB cases in India – a clear sign of their growing role in this national effort. Medical colleges are playing an increasingly important role in responding to the emerging trends in the TB epidemic. Extra-pulmonary forms of the disease that occur outside the lungs are on the rise and are generally harder to detect and treat. It now makes up 20-24% of all TB cases in India, especially among people with weaker immunity. With their advanced labs, specialist departments, and tertiary care capacity, medical colleges are uniquely positioned to deliver the multi-disciplinary care required to detect and manage these harder-to-treat cases. Medical colleges are also well placed to design and implement innovative health solutions, with research and practice occurring side by side. For example, the Bharati Vidyapeeth Medical College in Pune repurposed its Family Adoption Programme – where each student engages with five families over three years – to integrate community-based TB screening into the existing medical curriculum. This not only helped detect cases in the community, but also taught students to recognise key TB symptoms, demonstrating a scalable model for active case finding. One of our standout achievements has been fostering global collaborations. The ongoing partnership between AIIMS Gorakhpur and Johns Hopkins University through the TB-Free Schools initiative aimed at early detection, treatment, and prevention of TB among students in residential schools, demonstrates how Indian medical colleges can drive impactful international engagement. As this model is scaled, it reinforces what we have long championed—that medical colleges, when systematically integrated with state health systems, are among the most cost-effective and scalable platforms for delivering high-impact TB interventions. By leveraging these institutions, we can enhance passive case finding, improve diagnosis, and ensure timely treatment. With a structured mechanism for accountability under NTEP, medical colleges can become hubs for TB management. Furthermore, they are instrumental in building a competent healthcare workforce by integrating practical, programme-oriented TB management skills into the medical curriculum, thereby preparing a new generation of doctors for the challenges of TB elimination. Through a structured framework of national, zonal, and state-level task forces, medical colleges contribute to operational research, generating vital evidence to refine public health strategies and improve patient outcomes. By embedding themselves within the community through initiatives like the Family Adoption Programme, they also bolster active case finding efforts, ensuring early diagnosis and treatment, thus playing an indispensable and multifaceted role in India's journey towards a TB-free future. For TB and other critical public health challenges, where understanding patient behavior, treatment barriers, and local epidemiology is critical, the ability of medical colleges to connect science with ground-level implementation is key to turning policy into real-world action. They have technical expertise to strengthen surveillance systems, research capacity to strengthen monitoring and evaluation, and educational mandate to build local capability through supportive supervision. The integration of medical colleges into the TB elimination framework has been one of the most strategic shifts under the NTEP. Medical colleges have redefined their role in public health, not only by contributing to TB management, but by setting a precedent for how academic institutions can anchor systemic change. Their success is not incidental; it is the result of sustained collaboration, institutional commitment, and a shared vision of making India TB-free. Importantly, the integration of medical colleges into the TB response offers a replicable framework for tackling other complex health challenges in India – such as anti-microbial resistance, non-communicable diseases, and neglected tropical diseases – through a blend of research, education, service delivery, and community engagement. This article is authored by Dr Ashok Bhardwaj, professor emeritus, MM Medical & Hospital College Solan, Himachal Pradesh and chairperson of the National Task Force for Medical Colleges under NTEP and Dr Bhupendra Tripathi, deputy director, Infectious Diseases and Vaccine Delivery, Gates Foundation, India.
